Navigation Links
The Conference Forum confirms agenda for the 4th annual Mobile in Clinical Trials event on September 6, 2017
Date:8/14/2017

The Conference Forum has confirmed the one-day agenda for the Mobile in Clinical Trials event, which will take place on September 6, 2017 at the Marriott Copley Place in Boston, MA.

Returning as program chair is Daniel Karlin, MD, Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing how and when to implement mobile/digital technology in clinical trials and the potential benefits to be gained.

“Now in its fourth year, the Mobile program brings together speakers from key contributors to the development of digital technology in clinical trials,” says Conference Producer, Jennifer Moran. “Scheduled immediately before the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference at the same venue, this full-day event provides an ideal opportunity to discover more about the value of using digital tools in drug development.”

The event starts with opening remarks by chair Dan Karlin. The morning includes sessions on: how to overcome the cultural barriers to implementing mobile technology; CTTI’s findings on their mobile clinical trials program and recommendations on novel endpoints; case study learnings from Medidata; FDA guidance on implementing digital/mobile strategies and tools in clinical research; GSK’s PARADE study; Roche’s Parkinson’s disease study; and new technologies in live five-minute demonstrations.

The afternoon sessions cover: how to introduce digital tools in a clinical trial from start to finish; demonstrating value-added to a Phase IV trial by introducing a valid wearable; the current realities of the virtual trial model; Verily’s study watch tackling the scalability of wearables in clinical trials; the why, what, where and how of the digital coach in clinical trials; and a call to action and reflection on the the day’s learnings.

Find out more about Mobile in Clinical Trials.

About the Conference Forum
The Conference Forum is a research firm that develops specialized events for professionals in the life science and healthcare industries. The company currently offers conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange ideas and provide quality networking to help move therapeutics to patients faster.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14599593.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Palatin Technologies To Present At The 25th Annual ROTH Conference
7. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
8. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
9. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
10. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
11. Neogen Corporation Announces 3rd Quarter Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness ... targeting the needs of consumers who are incorporating medical marijuana into their wellness ... Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s two ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first ... accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):